Published in Biochemistry on November 27, 2001
Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity. Mol Cell Biol (2004) 1.73
Deciphering the genetic determinants for aerobic nicotinic acid degradation: the nic cluster from Pseudomonas putida KT2440. Proc Natl Acad Sci U S A (2008) 1.39
Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) (2009) 1.29
Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide. PLoS One (2011) 1.27
Life span extension and neuronal cell protection by Drosophila nicotinamidase. J Biol Chem (2008) 1.23
Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. BMC Microbiol (2010) 1.14
Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide. Angew Chem Int Ed Engl (2009) 1.14
Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance. Tuberculosis (Edinb) (2011) 1.05
Nicotinamidase modulation of NAD+ biosynthesis and nicotinamide levels separately affect reproductive development and cell survival in C. elegans. Development (2009) 1.04
Crystal structure of the yeast nicotinamidase Pnc1p. Arch Biochem Biophys (2007) 1.03
Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism. Biochemistry (2010) 0.98
Protein acetylation in metabolism - metabolites and cofactors. Nat Rev Endocrinol (2015) 0.97
Computational design of a pH-sensitive IgG binding protein. Proc Natl Acad Sci U S A (2013) 0.94
Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance. Infect Genet Evol (2009) 0.93
A New Family of Biuret Hydrolases Involved in S-Triazine Ring Metabolism. ACS Catal (2011) 0.92
Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis. Biochemistry (2010) 0.90
Biochemical and mutational analysis of a novel nicotinamidase from Oceanobacillus iheyensis HTE831. PLoS One (2013) 0.89
High-resolution crystal structures of Streptococcus pneumoniae nicotinamidase with trapped intermediates provide insights into the catalytic mechanism and inhibition by aldehydes . Biochemistry (2010) 0.88
Structure determination and characterization of the vitamin B6 degradative enzyme (E)-2-(acetamidomethylene)succinate hydrolase. Biochemistry (2010) 0.87
Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis. Bioinformation (2011) 0.86
Crystal structure and molecular modeling study of N-carbamoylsarcosine amidase Ta0454 from Thermoplasma acidophilum. J Struct Biol (2009) 0.84
Mechanisms of Pyrazinamide Action and Resistance. Microbiol Spectr (2013) 0.83
Molecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidase. PLoS One (2012) 0.82
Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase. Am J Trop Med Hyg (2012) 0.80
Structural and kinetic isotope effect studies of nicotinamidase (Pnc1) from Saccharomyces cerevisiae. Biochemistry (2011) 0.78
The evolutionary portrait of metazoan NAD salvage. PLoS One (2013) 0.77
Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility. BMC Genomics (2015) 0.77
Combined Whole-Cell High-Throughput Functional Screening for Identification of New Nicotinamidases/Pyrazinamidases in Metagenomic/Polygenomic Libraries. Front Microbiol (2016) 0.75
Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology. Infect Disord Drug Targets (2012) 0.75
Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China. Antimicrob Agents Chemother (2016) 0.75
Biogenesis and Homeostasis of Nicotinamide Adenine Dinucleotide Cofactor. Ecosal Plus (2009) 0.75
Metal-ion effects on the polarization of metal-bound water and infrared vibrational modes of the coordinated metal center of Mycobacterium tuberculosis pyrazinamidase via quantum mechanical calculations. J Phys Chem B (2014) 0.75
Biochemical characterization of a new nicotinamidase from an unclassified bacterium thriving in a geothermal water stream microbial mat community. PLoS One (2017) 0.75
A Key Enzyme of the NAD(+) Salvage Pathway in Thermus thermophilus: Characterization of Nicotinamidase and the Impact of Its Gene Deletion at High Temperatures. J Bacteriol (2017) 0.75
Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein. J Comput Aided Mol Des (2013) 0.75
An STS-based map of the human genome. Science (1995) 17.72
Three-dimensional tertiary structure of yeast phenylalanine transfer RNA. Science (1974) 11.02
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58
Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science (1990) 5.76
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (1994) 5.47
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Four-helical-bundle structure of the cytoplasmic domain of a serine chemotaxis receptor. Nature (1999) 5.38
Rapid evolution of male reproductive genes in the descent of man. Nature (2000) 5.33
Crystal structure of cyclin-dependent kinase 2. Nature (1993) 5.21
Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development (1995) 5.18
Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell (1998) 4.95
Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. Science (1991) 4.71
Crystal structure of the ATP-binding subunit of an ABC transporter. Nature (1998) 4.47
Three-dimensional structure of yeast phenylalanine transfer RNA: folding of the polynucleotide chain. Science (1973) 4.31
The general structure of transfer RNA molecules. Proc Natl Acad Sci U S A (1974) 4.30
Bone development. Annu Rev Cell Dev Biol (2000) 4.24
Electron transfer by domain movement in cytochrome bc1. Nature (1998) 4.08
Crystal structure of a small heat-shock protein. Nature (1998) 4.07
Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science (1988) 3.99
Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science (1989) 3.90
Sequential folding of transfer RNA. A nuclear magnetic resonance study of successively longer tRNA fragments with a common 5' end. J Mol Biol (1980) 3.63
Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn (2000) 3.59
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (1998) 3.53
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem (2000) 3.45
Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity (1999) 3.43
Crystal structure of yeast phenylalanine transfer RNA. II. Structural features and functional implications. J Mol Biol (1978) 3.41
Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell (1997) 3.23
Crystal structure of yeast phenylalanine transfer RNA. I. Crystallographic refinement. J Mol Biol (1978) 3.19
In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry (1994) 3.18
The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A (2000) 3.16
Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol (1999) 3.03
The folding mechanism of a beta-sheet: the WW domain. J Mol Biol (2001) 3.00
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A (1997) 2.99
BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell (2000) 2.94
Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93
Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron (2001) 2.92
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol (1993) 2.90
Burn wound infections: current status. World J Surg (1998) 2.86
Three-dimensional structure of yeast phenylalanine transfer RNA at 3.0angstroms resolution. Nature (1974) 2.85
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain (1994) 2.80
RNA-ligant interactions. (I) Magnesium binding sites in yeast tRNAPhe. Nucleic Acids Res (1977) 2.79
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature (2005) 2.74
Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science (1999) 2.71
Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71
Structure-based assignment of the biochemical function of a hypothetical protein: a test case of structural genomics. Proc Natl Acad Sci U S A (1998) 2.70
A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol (2000) 2.70
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
Concept for easy fiberoptic intubation via a laryngeal airway mask. Anesth Analg (1999) 2.67
The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67
Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol (1999) 2.65
Crystal structure of an RNA double helix incorporating a track of non-Watson-Crick base pairs. Nature (1991) 2.65
Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem (1997) 2.65
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Clin Cancer Res (2001) 2.64
DNA sequences of structural genes for Eco RI DNA restriction and modification enzymes. J Biol Chem (1981) 2.63
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA (1998) 2.60
Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol (1994) 2.59
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood (1999) 2.59
Atrial G protein-activated K+ channel: expression cloning and molecular properties. Proc Natl Acad Sci U S A (1993) 2.57
Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation (2001) 2.56
Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc (2001) 2.55
Hormonal changes in the grains of rice subjected to water stress during grain filling. Plant Physiol (2001) 2.52
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52
Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther (2001) 2.51
Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am (1999) 2.49
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The Madurai Intraocular Lens Study. II: Clinical outcomes. Am J Ophthalmol (1998) 2.46
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
Clp P represents a unique family of serine proteases. J Biol Chem (1990) 2.42
Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst (2001) 2.41
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood (1990) 2.38
Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev (2000) 2.38
Pattern of marine mass extinction near the Permian-Triassic boundary in South China. Science (2000) 2.38
De novo amyloid proteins from designed combinatorial libraries. Proc Natl Acad Sci U S A (1999) 2.38
An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet (2000) 2.36
Predicting caries in permanent teeth from caries in primary teeth: an eight-year cohort study. J Dent Res (2002) 2.35
ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1996) 2.33
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest (2000) 2.32
Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J (1999) 2.31
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Regulation and localization of the Bloom syndrome protein in response to DNA damage. J Cell Biol (2001) 2.30
Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol (2000) 2.30
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest (1998) 2.29
Three-dimensional structures of the periplasmic lysine/arginine/ornithine-binding protein with and without a ligand. J Biol Chem (1993) 2.27
Dietary information improves cardiovascular disease risk prediction models. Eur J Clin Nutr (2012) 2.26
Retained surgical sponge: diagnosis with CT and sonography. AJR Am J Roentgenol (1988) 2.25
A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proc Natl Acad Sci U S A (2000) 2.24
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24
Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol (2001) 2.22